At ISC 2016, Edward Ahearne, a Senior Analytical Scientist in AstraZeneca's Early Chemical Development New Modalities group, was interviewed by LCGC International on why his team combined automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results